Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Paternal cyclophosphamide treatment of rats causes fetal loss and malformations without affecting male fertility

Abstract

The use of cytotoxic, mutagenic and carcinogenic agents as treatment for various types of cancer may be particularly hazardous in men of reproductive age as there exists the possibility that this may lead to congenital malformations in the progeny. Such agents can affect fertility and other aspects of male reproductive function, for example, treatment with anti-cancer drugs such as cyclophosphamide has been associated with oligozoospermia, azoospermia and increased levels of serum follicle-stimulating hormone (FSH)1,2. Depending on the cumulative dose and the duration of treatment, spermatogenesis often returns but this may take years3,4. The relevance of the effects of such chemicals on the male reproductive system to the offspring is poorly understood. We have set out to determine whether present tests of male reproductive function (that is, endocrine status, numbers of spermatozoa, fertility) can predict deleterious effects of a paternally administered agent on the offspring. Here, we report that chronic administration in ratsof low doses of the widely used drug cyclophosphamide had minimal effects on the male reproductive system and fertility, but resulted in malformations and retardation of growth in the surviving fetuses and a high frequency of fetal death. Thus, adverse effects on the fetus cannot be predicted from the effects of a drug on the male reproductive system.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Schilsky, R. L., Lewis, B. J., Sherins, R. J. & Young, R. C. Ann. intern. Med. 93(1), 109–114 (1980).

    Article  CAS  Google Scholar 

  2. Chapman, R. M., Rees, L. H., Sutcliffe, S. B., Edwards, C. R. W. & Malpas, J. S. Lancet i, 285–289 (1979).

    Article  Google Scholar 

  3. Buchanan, J. D., Fairley, K. F. & Barrie, J. U. Lancet ii, 156–157 (1975).

    Article  Google Scholar 

  4. Roeser, H. P., Stochs, A. E. & Smith, A. J. Aust. NZ J. Med. 8, 250–254 (1978).

    Article  CAS  Google Scholar 

  5. Livingston, R. B. & Carter, S. K. Single Agents in Cancer Chemotherapy, 25–80 (IFI/Plenum, New York, 1970).

    Google Scholar 

  6. Clermont, Y. & Harvey, S. C. Endocrinology 76, 80–89 (1965).

    Article  CAS  Google Scholar 

  7. Clermont, Y. Physiol. Rev. 52(1), 198–236 (1972).

    Article  CAS  Google Scholar 

  8. Hales, B. F., Smith, S. & Robaire, B. Teratology 27(2), 47A (1983).

    Google Scholar 

  9. Amann, R. P. J. Androl. 2, 37–58 (1981).

    Article  Google Scholar 

  10. Zar, J. H. Biostatistical Analysis, 291–295 (Prentice-Hall, Englewood Cliffs, 1974).

    Google Scholar 

  11. Graul, E. H., Schaumloffel, E., Hundeshagen, H., Wilmanns, H. & Simon, G. Cancer 20(5), 896–899 (1967).

    Article  CAS  Google Scholar 

  12. Bagley, C. M., Bostick, F. W. & DeVita, V. T. Cancer Res. 33, 226–233 (1973).

    PubMed  Google Scholar 

  13. Botta, J. A. Jr, Hawkins, H. C. & Weikel, J. H. Jr Tox. appl Pharmac. 27, 602–611 (1974).

    Article  CAS  Google Scholar 

  14. Adams, P. M., Fabricant, J. D. & Legator, M. S. Science 211(2), 80–82 (1980).

    Article  ADS  Google Scholar 

  15. Moreland, F. M., Sheu, C. W., Springer, J. A. & Green, S. Mutat. Res. 90(2), 193–199 (1981).

    Article  CAS  Google Scholar 

  16. Allen, J. W. & Latt, S. A. Chromosoma 58, 325–340 (1976).

    Article  CAS  Google Scholar 

  17. Goetz, P., Malashenko, A. M. & Surkova, N. Folia biol., Praha 26, 289–297 (1980).

    CAS  Google Scholar 

  18. Brawer, J., Schipper, H. & Robaire, B. Endocrinology 112(1), 194–199 (1983).

    Article  CAS  Google Scholar 

  19. Scheer, H. & Robaire, B. Endocrinology 107(4), 948–953 (1980).

    Article  CAS  Google Scholar 

  20. Robb, G. W., Amann, R. P. & Killian, G. J. J. Reprod. Fert. 54, 103–107 (1978).

    Article  CAS  Google Scholar 

  21. Dunnet, C. W. in Statistics in Endocrinology (eds McArthur, J. W. & Colton, T.) 79–103 (MIT Press, Cambridge, 1967).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Trasler, J., Hales, B. & Robaire, B. Paternal cyclophosphamide treatment of rats causes fetal loss and malformations without affecting male fertility. Nature 316, 144–146 (1985). https://doi.org/10.1038/316144a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/316144a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing